SIILTIBCY® is poised to be the first skin test in Europe that accurately detects TB, regardless of BCG vaccination status EMA has given a positive recommendation, with a final decision on marketing approval expected by the end of 2024. Recommendation is based on comprehensive manufacturing…
EFI23 October 2024